Gamida Cell Ltd. financial data

Symbol
GMDA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5 Nahum Hafzadi Street, Jerusalem, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 23, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133 % -47.6%
Quick Ratio 5.32 %
Return On Equity 527 % -96.7%
Return On Assets -60.2 % +15.1%
Operating Margin -4.09 K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 154 M shares +26.7%
Common Stock, Shares, Outstanding 154 M shares +87.8%
Entity Public Float 217 M USD +110%
Common Stock, Value, Issued 416 K USD +87.4%
Weighted Average Number of Shares Outstanding, Basic 153 M shares +98.9%
Weighted Average Number of Shares Outstanding, Diluted 153 M shares +98.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 890 K USD
Cost of Revenue 916 K USD
Research and Development Expense 18.4 M USD -54.3%
General and Administrative Expense 29 M USD +24.6%
Costs and Expenses -464 K USD +60.4%
Operating Income (Loss) -78.6 M USD -4.44%
Nonoperating Income (Expense) 16.6 M USD
Net Income (Loss) Attributable to Parent -62 M USD +22.6%
Earnings Per Share, Basic 0.13 USD/shares -51.9%
Earnings Per Share, Diluted 0.13 USD/shares -51.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.8 M USD -47%
Marketable Securities, Current 6.22 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.03 M USD
Inventory, Net 1.97 M USD
Assets, Current 33.4 M USD -30.7%
Other Long-term Investments 1.29 M USD -18.2%
Property, Plant and Equipment, Net 40.2 M USD -11.9%
Operating Lease, Right-of-Use Asset 2.78 M USD -41.2%
Other Assets, Noncurrent 2.82 M USD +123%
Assets 79.6 M USD -24.3%
Accounts Payable, Current 5.43 M USD +23.5%
Employee-related Liabilities, Current 5.04 M USD +16.3%
Liabilities, Current 94.7 M USD +325%
Operating Lease, Liability, Noncurrent 1.85 M USD -37.9%
Other Liabilities, Noncurrent 1.46 M USD -46.9%
Liabilities 98.3 M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -417 M USD -23.5%
Retained Earnings (Accumulated Deficit) -500 M USD -14.2%
Stockholders' Equity Attributable to Parent -18.7 M USD -21.9%
Liabilities and Equity 79.6 M USD -24.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23 M USD -3.2%
Net Cash Provided by (Used in) Financing Activities 1.33 M USD -74.5%
Net Cash Provided by (Used in) Investing Activities -89 K USD +89.2%
Common Stock, Shares Authorized 325 M shares +117%
Common Stock, Shares, Issued 154 M shares +87.7%
Common Stock, Par or Stated Value Per Share 0.01 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.8 M USD -21.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.8 M USD -47%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.3 M USD +4.45%
Deferred Tax Assets, Valuation Allowance 46.6 M USD +17.8%
Deferred Tax Assets, Gross 46.9 M USD +16.8%
Operating Lease, Liability 2.98 M USD
Depreciation 1.13 M USD +966%
Payments to Acquire Property, Plant, and Equipment 89 K USD -89.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -31.7 M USD -70.7%
Lessee, Operating Lease, Liability, to be Paid 3.12 M USD -43.2%
Property, Plant and Equipment, Gross 46.1 M USD -5.48%
Operating Lease, Liability, Current 1.14 M USD -45.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 683 K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.04 M USD -49.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure -29.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 136 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 520 K USD -46.5%
Deferred Tax Assets, Operating Loss Carryforwards 42.1 M USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 525 K USD -25.4%
Depreciation, Depletion and Amortization 440 USD +2.09%
Share-based Payment Arrangement, Expense 3.86 M USD +11.6%
Interest Expense 7.59 M USD +33.5%